which streamers use streamlabs

CLEMSON, S.C. — Quarterback LaNorris Sellers could not be denied against Clemson. Neither could the South Carolina football team. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.PGA drops Vegas from next year's autumn schedule

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" 1914 translation by H. Rackham "But I must explain to you how all this mistaken idea of denouncing pleasure and praising pain was born and I will give you a complete account of the system, and expound the actual teachings of the great explorer of the truth, the master-builder of human happiness. No one rejects, dislikes, or avoids pleasure itself, because it is pleasure, but because those who do not know how to pursue pleasure rationally encounter consequences that are extremely painful. Nor again is there anyone who loves or pursues or desires to obtain pain of itself, because it is pain, but because occasionally circumstances occur in which toil and pain can procure him some great pleasure. To take a trivial example, which of us ever undertakes laborious physical exercise, except to obtain some advantage from it? But who has any right to find fault with a man who chooses to enjoy a pleasure that has no annoying consequences, or one who avoids a pain that produces no resultant pleasure?" Thanks for your interest in Kalkine Media's content! To continue reading, please log in to your account or create your free account with us.

Two teams headed in opposite directions square off Saturday afternoon in Salt Lake City when the Utah Jazz host the New York Knicks. The Jazz come in on a four-game losing streak, having most recently blown a huge lead at San Antonio on Thursday. They entered the weekend last in the Western Conference with just three wins on the season. Conversely, the Knicks bring a four-game winning streak to Utah after kicking off a five-game road trip Wednesday night with a victory at Phoenix. Coach Tom Thibodeau was pleased with how well the Knicks performed together in their 138-122 win over the short-handed Suns, who were missing injured stars Kevin Durant and Bradley Beal. "The guys are starting to get used to playing off of each other," Thibodeau said. "Each game you can see they're seeing things. They're reading the game extremely well. I think they're creating good spacing. They're cutting extremely well and what that's doing is it's opening up the floor and we're playing into space. And everyone's unselfish. We had 30 assists. I think that's huge." In the win at Phoenix, Jalen Brunson scored 23 points in the first half and Karl-Anthony Towns poured in 23 in the second half. Brunson finished with 36 points and 10 assists. He hit 12 of 21 field goals overall and drained 7 of 11 3-point attempts. Towns totaled 34 points on 12-of-19 shooting from the floor, adding 10 rebounds to help the Knicks continue their winning ways after two victories over Brooklyn and one against Washington. The Jazz came unraveled Thursday night after taking a 20-point first-half lead at San Antonio. Lauri Markkanen scored 27 and Keyonte George chipped in with 19 against the Spurs, who were playing without injured star center Victor Wembanyama. "I thought the first half, the energy, the tempo, the ball movement, the competitive spirit of the team was as good as we've seen in a while," Jazz coach Will Hardy said. That wasn't the case in the second half, however, as Utah gave up 75 points and was outscored by 12 points in both the third and fourth quarters. Reserve Brice Sensabaugh, who's seen inconsistent playing time, was a highlight for Utah in the first half, when he totaled 13 of his 18 points. "He has not complained. He's not had, like, a ‘woe-is-me' mentality. He's just come to work every day and he's taken some hard coaching," Hardy said. "He understands what's expected of him, but to his credit, he was ready, and he deserves all of the credit for that." Off to a tough start, the Jazz are hoping to find more consistency. The uneven play was evident against the Spurs, and it's been an issue at home, too. Utah returns to the Delta Center, usually a difficult venue for opponents, with just a 1-5 home record. "At the end of the day, you've got to play two halves," Collin Sexton said after scoring 18 for Utah. "We've got to play 48 minutes. You can't allow the first half to get you too high or get you too low, you've got to always stay consistent and just continue to build off of that." --Field Level MediaListenFirst Unveils Social Indexes for Sports, Revolutionizing the Game with Comprehensive Industry Insights on Social Media

Mutual of America Capital Management LLC cut its stake in shares of Pediatrix Medical Group, Inc. ( NYSE:MD – Free Report ) by 6.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 12,711 shares of the company’s stock after selling 897 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Pediatrix Medical Group were worth $147,000 at the end of the most recent reporting period. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Pediatrix Medical Group by 1.6% in the first quarter. Vanguard Group Inc. now owns 10,557,572 shares of the company’s stock worth $105,892,000 after acquiring an additional 164,333 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Pediatrix Medical Group by 4.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 87,369 shares of the company’s stock worth $877,000 after purchasing an additional 3,669 shares during the period. Tidal Investments LLC purchased a new stake in Pediatrix Medical Group during the 1st quarter valued at approximately $442,000. Virtu Financial LLC bought a new stake in shares of Pediatrix Medical Group during the first quarter valued at approximately $124,000. Finally, Boston Partners lifted its holdings in shares of Pediatrix Medical Group by 34.0% in the first quarter. Boston Partners now owns 1,786,434 shares of the company’s stock worth $17,702,000 after buying an additional 453,254 shares in the last quarter. 97.71% of the stock is owned by hedge funds and other institutional investors. Insider Activity at Pediatrix Medical Group In other Pediatrix Medical Group news, EVP Mary Ann E. Moore sold 8,108 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the sale, the executive vice president now directly owns 135,810 shares in the company, valued at approximately $2,172,960. This represents a 5.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . Also, Director Mark S. Ordan sold 27,600 shares of the firm’s stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total value of $423,660.00. Following the transaction, the director now owns 138,683 shares in the company, valued at approximately $2,128,784.05. This represents a 16.60 % decrease in their position. The disclosure for this sale can be found here . 2.00% of the stock is currently owned by company insiders. Wall Street Analysts Forecast Growth Read Our Latest Research Report on Pediatrix Medical Group Pediatrix Medical Group Stock Performance NYSE:MD opened at $14.96 on Friday. The firm has a market capitalization of $1.28 billion, a PE ratio of -4.89, a PEG ratio of 2.10 and a beta of 1.55. The stock’s fifty day moving average is $13.25 and its 200 day moving average is $10.21. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $16.41. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. Pediatrix Medical Group ( NYSE:MD – Get Free Report ) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.29 EPS. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current year. Pediatrix Medical Group Profile ( Free Report ) Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. Further Reading Five stocks we like better than Pediatrix Medical Group How to Invest in Blue Chip Stocks The Latest 13F Filings Are In: See Where Big Money Is Flowing Using the MarketBeat Dividend Tax Calculator 3 Penny Stocks Ready to Break Out in 2025 Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter .NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) is pleased to provide 2025 guidance including scope of the 2025 capital program along with production and Net Operating Income 1 (“NOI”) projections. Pieridae’s specific priorities for 2025 are: Sustain a safe and regulatory compliant business Minimize facility outages to maximize sales and processing revenue. Further grow the third-party gathering and processing business at our operated facilities. Meaningfully reduce operating expenses to improve corporate netback. Deliver attractive ROI on value adding optimization projects included in the 2025 capital program. Reduce long term debt to improve financial flexibility. The 2025 production guidance of 23,000 to 25,000 boe/d assumes that approximately 9,400 boe/d of previously announced voluntary production shut-ins in Central AB, Northern AB, and Northeast BC persist throughout 2025. These dry gas, low margin properties produce to third-party facilities and were shut-in during the second and third quarters of 2024 due to low AECO natural gas prices and high processing costs. These shut-ins represent approximately 25% of the Company’s production capability. Material production upside is possible if these properties are reactivated; management’s decision to reactivate production from any of these areas is subject to supportive long-term economics. The shut-in production can be restored within one to two weeks and subsequent well and reservoir performance is not expected to be negatively impacted. Pieridae has hedged 110,000 GJ/d of its 2025 natural gas production at a weighted average fixed price of $3.32/GJ, and 1,679 bbl/d of its 2025 condensate production with a weighted average floor price of CAD$84.41/bbl and a weighted average ceiling price of CAD$92.32/bbl. The Company’s aggregate hedge position for 2025 totals 19,055 boe/d or approximately 80% of the above production guidance range. The unrealized gain on the Company’s hedge portfolio, which extends to mid-2028, is approximately $87 million using the forward strip as of November 30, 2024. Pieridae’s legacy fixed price sulphur contract, which was entered into in 2019, expires on December 31, 2025. Under this contract, the Company receives a net fixed price of approximately $6/tonne for the majority of its sulphur production of approximately 1,400 tonnes per day. Beginning January 1, 2026, the Company will receive market price for all sulphur production, less normal deductions for transportation, handling, and marketing representing a significant potential revenue opportunity. As of November 30, 2024, the spot west coast sulphur price is approximately US$143/tonne, prior to transportation and marketing costs. The $25-$30 million capital budget in 2025 includes approximately $14 million directed towards a high-impact well and facility optimization program funded with the equity raised during Q3 and Q4 2024. These high return, short payout capital projects are expected to increase sales revenue, improve facility efficiency, reduce operating cost and fuel gas consumption, and lower GHG compliance costs. Spending on this program commenced in Q4 2024 and will continue throughout 2025. The remainder of the 2025 capital is focused on routine capital maintenance, field operating technology upgrades, and site closure / decommissioning expenditures in Alberta and BC. Notably, Pieridae has not scheduled a major maintenance turnaround planned at any of the Company’s deep-cut, sour gas processing facilities during 2025 given the successful completion of gas plant turnarounds and other maintenance projects in 2023 and 2024. The next major maintenance turnaround is scheduled for 2026. Due to the current outlook for North American natural gas prices, Pieridae is not planning to resume drilling operations during 2025. Pieridae will only exploit its portfolio of high impact conventional Foothills drilling opportunities once natural gas prices sustainably recover and the Company has achieved its deleveraging target. ABOUT PIERIDAE Pieridae is a Canadian energy company headquartered in Calgary, Alberta. The Company is a significant upstream producer and midstream custom processor of natural gas, NGLs, condensate, and sulphur from the Canadian Foothills and adjacent areas in Alberta and in northeast British Columbia. Pieridae’s vision is to provide responsible, affordable natural gas and derived products to meet society’s energy security needs. Pieridae’s common shares trade on the TSX under the symbol “PEA”. For further information, visit www.pieridaeenergy.com , or please contact: Forward-Looking Statements Certain of the statements contained herein including, without limitation, management plans and assessments of future plans and operations, Pieridae’s outlook, strategy and vision, intentions with respect to future acquisitions, dispositions and other opportunities, including exploration and development activities, Pieridae’s ability to market its assets, plans and timing for development of undeveloped and probable resources, Pieridae’s goals with respect to the environment, relations with Indigenous people and promoting equity, diversity and inclusion, estimated abandonment and reclamation costs, plans regarding hedging, plans regarding the payment of dividends, wells to be drilled, the weighting of commodity expenses, expected production and performance of oil and natural gas properties, results and timing of projects, access to adequate pipeline capacity and third-party infrastructure, growth expectations, supply and demand for oil, natural gas liquids and natural gas, industry conditions, government regulations and regimes, capital expenditures and the nature of capital expenditures and the timing and method of financing thereof, may constitute “forward-looking statements” or “forward-looking information” within the meaning of applicable securities laws (collectively “ forward-looking statements ”). Words such as “may”, “will”, “should”, “could”, “anticipate”, “believe”, “expect”, “intend”, “plan”, “continue”, “focus”, “endeavor”, “commit”, “shall”, “propose”, “might”, “project”, “predict”, “vision”, “opportunity”, “strategy”, “objective”, “potential”, “forecast”, “estimate”, “goal”, “target”, “growth”, “future”, and similar expressions may be used to identify these forward-looking statements. These statements reflect management's current beliefs and are based on information currently available to management. Forward-looking statements involve significant risk and uncertainties. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements including, but not limited to, the risks associated with oil and gas exploration, development, exploitation, production, processing, marketing and transportation, loss of markets, volatility of commodity prices, currency fluctuations, imprecision of resources estimates, environmental risks, competition from other producers, incorrect assessment of the value of acquisitions, failure to realize the anticipated benefits of acquisitions, delays resulting from or inability to obtain required regulatory approvals, ability to access sufficient capital from internal and external sources and the risk factors outlined under “Risk Factors” and elsewhere herein. The recovery and resources estimate of Pieridae's reserves provided herein are estimates only and there is no guarantee that the estimated resources will be recovered. As a consequence, actual results may differ materially from those anticipated in the forward-looking statements. Forward-looking statements are based on a number of factors and assumptions which have been used to develop such forward-looking statements, but which may prove to be incorrect. Although Pieridae believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements because Pieridae can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this document, assumptions have been made regarding, among other things: the impact of increasing competition; the general stability of the economic and political environment in which Pieridae operates; the timely receipt of any required regulatory approvals; the ability of Pieridae to obtain and retain qualified staff, equipment and services in a timely and cost efficient manner; the ability of the operator of the projects which Pieridae has an interest in to operate the field in a safe, efficient and effective manner; the ability of Pieridae to obtain financing on acceptable terms; the ability to replace and expand oil and natural gas resources through acquisition, development and exploration; the timing and costs of pipeline, storage and facility construction and expansion and the ability of Pieridae to secure adequate product transportation; future oil and natural gas prices; currency, exchange and interest rates; the regulatory framework regarding royalties, taxes and environmental matters in the jurisdictions in which Pieridae operates; timing and amount of capital expenditures; future sources of funding; production levels; weather conditions; success of exploration and development activities; access to gathering, processing and pipeline systems; advancing technologies; and the ability of Pieridae to successfully market its oil and natural gas products. Readers are cautioned that the foregoing list of factors is not exhaustive. Additional information on these and other factors that could affect Pieridae's operations and financial results are included in reports on file with Canadian securities regulatory authorities and may be accessed through the SEDAR+ website (www.sedarplus.ca), and at Pieridae's website (www.pieridaeenergy.com). Although the forward-looking statements contained herein are based upon what management believes to be reasonable assumptions, management cannot assure that actual results will be consistent with these forward-looking statements. Investors should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and Pieridae assumes no obligation to update or review them to reflect new events or circumstances except as required by applicable securities laws. Forward-looking statements contained herein concerning the oil and gas industry and Pieridae's general expectations concerning this industry are based on estimates prepared by management using data from publicly available industry sources as well as from reserve reports, market research and industry analysis and on assumptions based on data and knowledge of this industry which Pieridae believes to be reasonable. However, this data is inherently imprecise, although generally indicative of relative market positions, market shares and performance characteristics. While Pieridae is not aware of any misstatements regarding any industry data presented herein, the industry involves risks and uncertainties and is subject to change based on various factors. Additional Reader Advisories Barrels of oil equivalent (“boe”) may be misleading, particularly if used in isolation. A boe conversion ratio of 6 Mcf: 1 boe is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. Abbreviations Neither TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Are you still hunting around for last-minute gift ideas and substantive stocking stuffers? Instead of loading your loved one’s mantle-mounted sock up with candy and whatever Walmart or Target has hanging around in the checkout lanes, why not turn your attention to an awesome pair of Beats headphones? As a matter of fact, you’ll even be able to save a few dollars on one of the best over-ear pairs of cans the company makes: Right now, when you purchase the Beats Studio Pro Wireless Noise-Cancelling Headphones through Best Buy, you’ll only pay $150. At full price, this model sells for $200. We tested these cans back in July 2023 , and reviewer Simon Cohen said the Beats Studio Pro “offer some much-needed enhancements. And not a moment too soon.” We also recommend taking a look at some of the other great Best Buy deals we’ve been tracking down. Why you should buy the Beats Studio Pro Renowned for its warm, bass-friendly sound signatures on both its headphone and earbud products, Beats is a terrific choice when it comes to listening to music and podcasts. We’d even recommend using the Studio Pro for watching movies and playing video games! Not only are the controls intuitive and easy to recall, but the Studio Pro feel comfortable to wear for long periods, and they deliver clear and balanced sound. These premium headphones also deliver class-leading ANC, helping to deaden the sounds of the bustling world around you. We’re also glad to see that these headphones support head-tracking sound (or Spatial Audio) as well as lossless, wired USB-C playback. On a full charge, you can expect the Studio Pro to last up to 40 hours with ANC disabled and around 24 hours of playback with ANC turned on. We’re not sure how long this discount is going to stick around, so today might be the best day to save big on Beats! Take $50 off the Beats Studio Pro when you purchase through Amazon, Best Buy, and a couple of other retailers. We also suggest taking a look at our lists of the best Beats headphone deals and best headphone deals .